“day iv toxicity studies were considered the pivotal toxicity studies which cover the clinical dosing route and duration.”
✓ VerifiedFDA pharmacology/toxicology review, p. 44Source ↗
Pivotal GLP studies
7-day iv studies plus additional oral rat (up to 28-day) and dog (up to 14-day) studies
“Additional oral toxicity studies in rats (up to 28-days) and dogs (up to 14-days) assessed longer term trilaciclib exposures and confirmed similar total drug exposure from repeated oral and iv dosing. Dose-limiting toxicity in the 14-day and 28-day studies was consistent with exaggerated pharmacology and generally similar to the 7-day iv toxicity study results.”
✓ VerifiedFDA pharmacology/toxicology review, p. 44Source ↗
Route in tox
Intravenous (30-min infusion)
“Seven-day iv (30 min infusion) pilot toxicity in dogs with a two-week drug-free recovery phase.”
✓ VerifiedFDA pharmacology/toxicology review, p. 48Source ↗